Focus on HER3 in cancer: Summary
HER3 is a key component of HER2-mediated tumorigenesis
- HER3 is a requirement for HER2 signaling in cancer1
- HER3 enables HER2 signaling by dimerizing with HER2
- Effects of HER2/HER3 signaling include:
- Activation of the PI3K signaling pathway1
- Escape from HER2 inhibition6
HER3 is a negative prognostic factor
- HER3 overexpression has been correlated with:
- Shorter disease-free survival in breast cancer11
- Shorter overall survival in ovarian cancer2
HER3 represents a potential therapeutic target
- Methods of targeting could include:
- Targeting HER2/HER3 dimerization20
- Targeting HER3 ligands
- Targeting downstream signaling pathways1
Additional clinical research is needed to better clarify the role of HER3 in cancer.

